(Correction) Notice of Partial Correction to “Presentation Materials”
Filed with TSE · · 2 pages · English
TMS Co., Ltd. (TSE: 4891) (the "Company") hereby announces that certain corrections have been made to the “Presentation Material for the Six Months Ended June 30, 2026” which were disclosed on August 14, 2026. Details of the Correction Please refer to the attached document. The corrected sections are enclosed in red boxes. The Company has posted the corrected version of the “Presentation Material
Earlier from TMS
- Non-consolidated Financial Results for the Six Months Ended June 30, 2026 [Japanese GAAP]
- Mindful Health Solutions Advances Patient Experience with Sohar Health's Verification Solution
Later from TMS
- Notice of Submission of a Clinical Trial Plan Notification for a Phase IIa Clinical Trial of TMS-008 for Acute Kidney Injury
- Notice of Completion of PMDA’s 14-Day Review Period for the TMS-008 Phase IIa Clinical Trial
Follow TMS into a list and get an email when it puts out news.
Follow TMS